Target intelligence / Profile preview

Coronary artery smooth muscle (VSMC)

Target
VSMC
Molecular classification
Other (cell type, not a single molecular entity), For individual molecular targets on/in these cells, classifications would include "Receptor", "Ion channel", "Enzyme", etc., depending on the specific protein
01

Overview

Coronary artery smooth muscle refers to the collection of vascular smooth muscle cells (VSMCs) that reside in the tunica media of the coronary arteries. These cells regulate arterial tone, blood flow, and blood pressure through contraction and relaxation, acting under autonomic and humoral control. In disease states such as atherosclerosis and restenosis, VSMCs play critical and complex roles: contributing to plaque growth and stability, undergoing phenotypic switching to macrophage-like or osteogenic forms, and participating in fibrosis and scar tissue formation. Although not a single molecular target, numerous proteins and pathways within coronary artery VSMCs represent current and emerging therapeutic opportunities to treat or prevent coronary artery disease, restenosis, and related vascular pathologies. For structured and mechanistic insight, it is essential to specify the exact molecular entity of interest on, or within, these cells (e.g., "L-type calcium channel," "SMC α-actin," "TGF-β receptor") as opposed to the general cell type.

Other names
Vascular smooth muscle cell (VSMC)Coronary artery vascular smooth muscle cellArterial smooth muscle cell
02

Mechanism of action

(For drugs acting on VSMCs generally) - Inhibition of cell proliferation (blocking DNA/RNA synthesis) - Cytoskeletal modulation, prevention of migration and remodeling - Inhibition of phenotypic switching or foam cell formation - Modulation of vasomotor tone through calcium channel blockade or NO release.

03

Biological functions

Regulation of vascular tone (vasoconstriction/vasodilation)Control of blood pressure and coronary blood flowPhenotypic switching (contractile ↔ synthetic/proliferative)Contribution to arterial remodeling, atherosclerosis, restenosis, plaque stabilityExtracellular matrix production
04

Disease associations

Cardiovascular disease (especially atherosclerosis, restenosis, coronary artery disease)Vascular injury response and neointima formationFibrosis and scar tissue development
05

Safety considerations

Targeting VSMCs indiscriminately can impair vascular repair, re-endothelialization, and compromise vessel integrity, as seen with some drug-eluting stentsPhenotypic switching may have dual roles: protective (fibrous cap formation) and harmful (increased plaque instability) depending on contextOff-target effects on non-diseased vasculature and risk of promoting vessel wall weakness or rupture
06

Interacting drugs

Antiproliferative drugs used in drug-eluting stents: paclitaxel, sirolimus/rapamycin

2 more in the full profile.

07

Biomarkers

None specific to "coronary artery smooth muscle" as a single entity; potential markers are used in research such as:α-smooth muscle actin (α-SMA)Smooth muscle 22αMarkers of phenotypic transition, e.g., osteoprotegerin, Pit-1/Pit-2

Beyond the preview

Go deeper on Coronary artery smooth muscle (VSMC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coronary artery smooth muscle (VSMC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call